Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers
Status: | Completed |
---|---|
Conditions: | Smoking Cessation, Tobacco Consumers |
Therapuetic Areas: | Pulmonary / Respiratory Diseases |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 10/8/2017 |
Start Date: | October 22, 2012 |
End Date: | August 28, 2015 |
Pilot Study of Varenicline vs. Nicotine Patch Delivered by a Telephone Quitline to Promote Smoking Cessation
This pilot clinical trial studies varenicline or nicotine patch in promoting smoking
cessation among current smokers. Varenicline or nicotine patch may help people stop smoking
cessation among current smokers. Varenicline or nicotine patch may help people stop smoking
PRIMARY OBJECTIVES:
I. To determine if mail delivery of 12 weeks of varenicline results in improved smoking
cessation outcomes relative to nicotine replacement therapy (NRT) in 300 smokers.
II. To determine if delivery of varenicline is cost-effective as compared to nicotine patch.
OUTLINE: Patients are randomized to 1 of 2 treatment arms.
ARM I: Patients undergo general smoking cessation counseling and receive varenicline orally
(PO) twice daily (QD) on days 1-28. Courses repeat every 28 days for up to 12 weeks.
ARM II: Patients undergo general smoking cessation counseling and receive nicotine patch
continuously for 12 weeks.
After completion of study treatment, patients are followed up at 4 months.
I. To determine if mail delivery of 12 weeks of varenicline results in improved smoking
cessation outcomes relative to nicotine replacement therapy (NRT) in 300 smokers.
II. To determine if delivery of varenicline is cost-effective as compared to nicotine patch.
OUTLINE: Patients are randomized to 1 of 2 treatment arms.
ARM I: Patients undergo general smoking cessation counseling and receive varenicline orally
(PO) twice daily (QD) on days 1-28. Courses repeat every 28 days for up to 12 weeks.
ARM II: Patients undergo general smoking cessation counseling and receive nicotine patch
continuously for 12 weeks.
After completion of study treatment, patients are followed up at 4 months.
Inclusion Criteria:
- Cigarette smokers who call the New York State Smokers' Quitline requesting assistance
with quitting smoking
- State that they are under the care of a primary care physician
- Are eligible for receipt of pharmacotherapy by mail using the standard NRT criteria
- Speak English
- Answer "no" to the following 3 questions:
- "Have you ever been diagnosed with or treated for a mental health problem like
major depression, bipolar disorder, dysthymia, or schizoaffective disorder?"
- "Have you ever had serious thoughts of killing or hurting yourself, ever have any
intention or plan to carry out these thoughts, or actually attempted to kill
yourself?"
- "Is there any reason that you cannot use varenicline/Chantix?"
Exclusion Criteria:
- State that they are not under the care of a primary care physician
- Are not eligible for receipt of pharmacotherapy by mail using the standard NRT
criteria
- Do not speak English
- Answer "yes" to the question, "have you ever been diagnosed with or treated for a
mental health problem like major depression, bipolar disorder, dysthymia, or
schizoaffective disorder?"
- Answer "yes" to the question, "have you ever had serious thoughts of killing or
hurting yourself, ever have any intention or plan to carry out these thoughts, or
actually attempted to kill yourself?"
- Answer "yes" to the question, "is there any reason that you cannot use
varenicline/Chantix?"
- Are women who are currently pregnant
- Report that they are unwilling to receive or take varenicline on screening
We found this trial at
1
site
Roswell Park Cancer Institute Welcome to Roswell Park Cancer Institute (RPCI), America's first cancer center...
Click here to add this to my saved trials